Institutional investors hold a majority ownership of CELG through the 82.51% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
SUSQUEHANNA FINANCIAL GROUP LLLP Bought 1.8 Million shares of Celgene
MONTAG & CALDWELL LLC Bought 1.3 Million shares of Celgene
BT INVESTMENT MANAGEMENT LTD. (I... Bought 1.3 Million shares of Celgene